Decoy Therapeutics Inc. (DCOY) › Cash & EquivalentsDecoy Therapeutics Inc. (DCOY) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2017: $19.19M2018: $3.23M2019: $3.74M2020: $11.12M2021: $29.21M2022: $12.11M2023: $5.90M2024: $2.43M2025: $10.71M$10.71M2017Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$10.71M+339.9%2024$2.43M-58.7%2023$5.90M-51.3%2022$12.11M-58.6%2021$29.21M+162.8%2020$11.12M+197.4%2019$3.74M+15.8%2018$3.23M-83.2%2017$19.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share